CircTMTC1 accelerates NPC progression through targeting miR-495 and consequently activating the MET-eIF4G1 translational regulation axis, suggesting potential therapeutic targets for NPC treatment. The gene discussed is EIF4G1; the disease is nasopharyngeal carcinoma.